Investing

Top Analyst Upgrades and Downgrades: AK Steel, CenterPoint, Marvell, Nike, Salesforce, Tesla, Tyson Foods, UnitedHealth, Zscaler and More

NetEase Inc. (NASDAQ: NTES) was raised to Buy from Neutral and the target price was raised to $368 from $300 (versus a $317.32 close) at Goldman Sachs.

Nike Inc. (NYSE: NKE) was named as the Bull of the Day at Zacks, which said that this stock has outpaced its broader industry in 2019 and it looks poised to continue to expand around the globe. The shares most recently closed at $92.46, with a consensus price target of $102.40.

Owens Corning (NYSE: OC) was downgraded to Neutral from Buy at Merrill Lynch.

Primo Water Corp. (NASDAQ: PRMW) was maintained as Outperform but the target price was lowered to $14 from $15 (versus a $10.48 close) at Imperial Capital.

Salesforce.com Inc. (NYSE: CRM) was up 0.35% at $161.57 ahead of earnings but was last seen down about 0.5% at $160.85 afterward and guidance seemed to be more steady and predictable. Credit Suisse maintained its Outperform rating and raised its target to $185 from $175, and Wedbush Securities maintained its Outperform rating with a $192 target price. Morgan Stanley reiterated its Overweight rating and raised its target to $197 from $180.

Tesla Inc. (NASDAQ: TSLA) was maintained with a Sell rating at Citigroup, but the firm raised its target price to $222 from $191. Tesla closed up 0.4% at $336.20 on Tuesday, with a consensus target price of about $278.50.

Tyson Foods Inc. (NYSE: TSN) was maintained as Neutral but its target price was raised to $89 from $83 at JPMorgan.

UnitedHealth Group Inc. (NYSE: UNH) was down 1% at $276.90 on Tuesday, but shares were up 1.3% at $280.62 ahead of Wednesday’s opening bell. Wells Fargo reiterated its Outperform rating and raised its target to $318 from $288. Credit Suisse reiterated it as Outperform and raised its target price to $320 from $293, and Cantor Fitzgerald reiterated its Overweight rating and raised its target from $310 to $315.

ViewRay Inc. (NASDAQ: VRAY) was up 30.6% at $4.44 on Tuesday after announcing a collaboration with Medtronic and Elekta, and even the announcement of a secondary offering only had shares down close to 2% on Wednesday. B. Riley downgraded the shares to Neutral from Buy and cut its target to $5 from $9.

Zimmer Biomet Holdings Inc. (NYSE: ZBH) was upgraded to Strong Buy from Outperform and the price target was raised to $170 from $160 at Raymond James.

Zscaler Inc. (NASDAQ: ZS) closed up 3.4% at $52.80 ahead of earnings but its guidance had shares down 5% at $50.15 as the mostly in-line forecast still has very high valuations that are hard to justify. Wedbush reiterated its Outperform rating and $80 target price after noting that the company had strong performance with billings and its new CRO is making an impact out of the gates. Merrill Lynch reiterated its Buy rating and raised its price objective to $70 from $68.

Tuesday’s top analyst upgrades and downgrades included Alphabet, Amazon.com, Beyond Meat, CommScope, Enphase Energy, Nabors Industries, Netflix, Nike, Roku, Tesla, Uber Technologies, Williams Companies and many more.